To the Editor Dr Barnell and colleagues reported an mt-sRNA colorectal cancer screening test with higher sensitivity for colorectal cancer compared with FIT (94.4% for mt-sRNA vs 77.8% for FIT). Although sensitivity is important in colorectal cancer screening, I believe the description of the lower specificity of mt-sRNA compared with FIT is misleading.